Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

COVID-19

Free Subscription Articles published in JAMA Retrieve available abstracts of 489 articles: HTML format

Single Articles

January 2026
1. PRASAD V, Makary MA
   FDA Labeling Change for mRNA COVID-19 Vaccines-Reply.
   JAMA. 2026 Jan 7. doi: 10.1001/jama.2025.21754.
   PubMed    
   
   
   
2. MEYEROWITZ EA
   FDA Labeling Change for mRNA COVID-19 Vaccines.
   JAMA. 2026 Jan 7. doi: 10.1001/jama.2025.21752.
   PubMed    
   
   
   
3. ANDERER S
   COVID-19 in Pregnancy Linked With Risk of Neurodevelopmental Disorders in Early Childhood.
   JAMA. 2026 Jan 2. doi: 10.1001/jama.2025.23090.
   PubMed    
   
   
   December 2025
4. DEVANAND DP, Wisniewski T, Razlighi Q, Qian M, et al
   Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial.
   JAMA. 2025 Dec 17:e2521738. doi: 10.1001/jama.2025.21738.
   PubMed     Abstract available
   
   
   
5. MCCLYMONT E, Blitz S, Forward L, Cole S, et al
   The Role of Vaccination in Maternal and Perinatal Outcomes Associated With COVID-19 in Pregnancy.
   JAMA. 2025 Dec 15:e2521001. doi: 10.1001/jama.2025.21001.
   PubMed     Abstract available
   
   
   
6. GIAMARELLOS-BOURBOULIS EJ, Kotsaki A, Kotsamidi I, Efthymiou A, et al
   Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical Trial.
   JAMA. 2025 Dec 8:e2524175. doi: 10.1001/jama.2025.24175.
   PubMed     Abstract available
   
   
   November 2025
7. PANT S
   2024-2025 COVID-19 Vaccines Protected Against JN.1 Subvariants.
   JAMA. 2025 Nov 14. doi: 10.1001/jama.2025.19733.
   PubMed    
   
   
   
8. FRIEDEN TR, Schaffner W, Sharfstein JM
   CDC's Failure to Recommend COVID-19 Vaccination-"Shared Clinical Decision-Making" Is Abdication of Responsibility.
   JAMA. 2025 Nov 13. doi: 10.1001/jama.2025.22473.
   PubMed    
   
   
   
9. PANT S
   New COVID-19 Vaccination Guidelines for Immunocompromised Individuals.
   JAMA. 2025 Nov 7. doi: 10.1001/jama.2025.19727.
   PubMed    
   
   
   October 2025
10. PANT S
    First-Trimester COVID-19 Vaccination Not Associated With Congenital Risks.
    JAMA. 2025 Oct 31. doi: 10.1001/jama.2025.17533.
    PubMed    
    
    
    
11. SCHWANDT H, Kowarski J, Woolf SH
    Life Expectancy After the COVID-19 Pandemic-Reply.
    JAMA. 2025 Oct 27. doi: 10.1001/jama.2025.16405.
    PubMed    
    
    
    
12. WILSON KT, Esposito ML, Martinez A
    Life Expectancy After the COVID-19 Pandemic.
    JAMA. 2025 Oct 27. doi: 10.1001/jama.2025.16403.
    PubMed    
    
    
    
13. ABBASI J
    New Guidance on Cardiovascular Disease and COVID-19-From Infection to Long COVID to Vaccination.
    JAMA. 2025 Oct 24. doi: 10.1001/jama.2025.18834.
    PubMed    
    
    
    
14. SAUGEL B, Meidert AS, Brunkhorst FM, Bischoff R, et al
    Individualized Perioperative Blood Pressure Management in Patients Undergoing Major Abdominal Surgery: The IMPROVE-multi Randomized Clinical Trial.
    JAMA. 2025 Oct 12:e2517235. doi: 10.1001/jama.2025.17235.
    PubMed     Abstract available
    
    
    
15. ANDERER S
    COVID-19 Linked to Lasting and Underrecognized Smell Impairment.
    JAMA. 2025 Oct 10. doi: 10.1001/jama.2025.17491.
    PubMed    
    
    
    
16. SHAH J
    Through the Glass.
    JAMA. 2025 Oct 9. doi: 10.1001/jama.2025.18165.
    PubMed    
    
    
    September 2025
17. ANDERER S
    Updated COVID-19 Vaccine Generates Strong Immune Response.
    JAMA. 2025 Sep 26. doi: 10.1001/jama.2025.13887.
    PubMed    
    
    
    
18. ANDERER S
    Nasal Spray May Help Prevent COVID-19 Infection.
    JAMA. 2025 Sep 19. doi: 10.1001/jama.2025.13883.
    PubMed    
    
    
    
19. RUDMAN SPERGEL AK, Callendret B, Kostanyan L
    Influenza and COVID-19 Multicomponent Vaccine in Adults-Reply.
    JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12225.
    PubMed    
    
    
    
20. LIU Z, Zhang L, Jiang M
    Influenza and COVID-19 Multicomponent Vaccine in Adults.
    JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12222.
    PubMed    
    
    
    
21. ANDERER S
    Breaking From CDC, ACOG Continues Recommending COVID-19 Vaccine During Pregnancy.
    JAMA. 2025 Sep 5. doi: 10.1001/jama.2025.16943.
    PubMed    
    
    
    August 2025
22. SURIE D, Self WH, Yuengling KA, Lauring AS, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons.
    JAMA. 2025 Aug 30:e2515896. doi: 10.1001/jama.2025.15896.
    PubMed     Abstract available
    
    
    
23. ANDERER S
    COVID-19, Flu May Reawaken Dormant Cancer Cells.
    JAMA. 2025 Aug 29. doi: 10.1001/jama.2025.14772.
    PubMed    
    
    
    
24. ANDERER S
    COVID-19 Vaccines Averted 2.5 Million Deaths, Mostly Among Older Adults.
    JAMA. 2025 Aug 15. doi: 10.1001/jama.2025.11001.
    PubMed    
    
    
    
25. TURNER NA, Hamasaki T, Doernberg SB, Lodise TP, et al
    Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial.
    JAMA. 2025 Aug 13. doi: 10.1001/jama.2025.12543.
    PubMed     Abstract available
    
    
    
26. ANDERER S
    Booster Shots Help Prevent Severe COVID-19 in People With Cancer.
    JAMA. 2025 Aug 8. doi: 10.1001/jama.2025.10996.
    PubMed    
    
    
    
27. RUBIN R
    SARS-CoV-2 Variants Challenge Surveillance Efforts and COVID-19 Vaccines.
    JAMA. 2025 Aug 1. doi: 10.1001/jama.2025.12273.
    PubMed    
    
    
    July 2025
28. BAKER LD, Espeland MA, Whitmer RA, Snyder HM, et al
    Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial.
    JAMA. 2025 Jul 28:e2512923. doi: 10.1001/jama.2025.12923.
    PubMed     Abstract available
    
    
    
29. SCHNEIDER L
    WHO Report Suggests Likely Zoonotic Origin of COVID-19, Doesn't Rule Out Lab Leak.
    JAMA. 2025 Jul 25. doi: 10.1001/jama.2025.10976.
    PubMed    
    
    
    
30. PRASAD V, Makary MA
    US FDA Safety Labeling Change for mRNA COVID-19 Vaccines.
    JAMA. 2025 Jul 14. doi: 10.1001/jama.2025.12675.
    PubMed    
    
    
    
31. RUBIN R
    The CDC No Longer Recommends COVID-19 Shots During Pregnancy-Now What?
    JAMA. 2025 Jul 11. doi: 10.1001/jama.2025.11889.
    PubMed    
    
    
    
32. SCHWANDT H, Currie J, von Wachter T, Kowarski J, et al
    The Failure of Life Expectancy to Fully Rebound to Prepandemic Levels.
    JAMA. 2025 Jul 9:e2510439. doi: 10.1001/jama.2025.10439.
    PubMed    
    
    
    
33. STAR J, Bandi P
    Cancer Screening After the Onset of the COVID-19 Pandemic-Reply.
    JAMA. 2025 Jul 7. doi: 10.1001/jama.2025.6934.
    PubMed    
    
    
    
34. WU G, Yin J, Huang Y
    Cancer Screening After the Onset of the COVID-19 Pandemic.
    JAMA. 2025 Jul 7. doi: 10.1001/jama.2025.6931.
    PubMed    
    
    
    June 2025
35. GRUNEBAUM A, Chervenak FA
    Professional Responsibility for COVID-19 Vaccination in Pregnancy.
    JAMA. 2025 Jun 25. doi: 10.1001/jama.2025.11328.
    PubMed    
    
    
    
36. GOSTIN LO, Reiss D, Offit PA
    Changed Recommendations for COVID-19 Vaccines for Children and Pregnant Women: A Failure of Process, Policy, and Science.
    JAMA. 2025 Jun 13. doi: 10.1001/jama.2025.10658.
    PubMed    
    
    
    
37. ZETTLER PJ, Cha S, Despres S, Lurie P, et al
    FDA Review of Novavax's COVID-19 Vaccine-Regulatory Integrity and Deviations From Standard Practice.
    JAMA. 2025 Jun 9. doi: 10.1001/jama.2025.9898.
    PubMed    
    
    
    
38. NGUYEN T, Whaley C, Simon KI, Cantor J, et al
    Health Care Workforce Recovery After the End of the COVID-19 Emergency.
    JAMA. 2025 Jun 5. doi: 10.1001/jama.2025.8588.
    PubMed    
    
    
    May 2025
39. RUDMAN SPERGEL AK, Wu I, Deng W, Cardona J, et al
    Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults >/=50 Years: A Randomized Clinical Trial.
    JAMA. 2025 May 7:e255646. doi: 10.1001/jama.2025.5646.
    PubMed     Abstract available
    
    
    April 2025
40. KIANG MV, Bubar KM, Maldonado Y, Hotez PJ, et al
    Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US.
    JAMA. 2025 Apr 24. doi: 10.1001/jama.2025.6495.
    PubMed     Abstract available
    
    
    
41. MOIN EE, Seewald NJ, Halpern SD
    Use of Life Support and Outcomes Among Patients Admitted to Intensive Care Units.
    JAMA. 2025 Apr 14:e252163. doi: 10.1001/jama.2025.2163.
    PubMed     Abstract available
    
    
    March 2025
42. LAURING AS, Edson C, Surie D, Dawood FS, et al
    Genomic Characterization of RSV in the US by Vaccination Status.
    JAMA. 2025 Mar 10. doi: 10.1001/jama.2025.1225.
    PubMed    
    
    
    
43. STAR J, Han X, Smith RA, Schafer EJ, et al
    Cancer Screening 3 Years After the Onset of the COVID-19 Pandemic.
    JAMA. 2025 Mar 5:e250902. doi: 10.1001/jama.2025.0902.
    PubMed    
    
    
    February 2025
44. HANLON P, Butterly E, Wei L, Wightman H, et al
    Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.
    JAMA. 2025 Feb 3:e2427402. doi: 10.1001/jama.2024.27402.
    PubMed     Abstract available
    
    
    January 2025
45. ANDERER S
    COVID-19 Tied to Long-Term Kidney Function Decline.
    JAMA. 2025 Jan 24. doi: 10.1001/jama.2024.28058.
    PubMed    
    
    
    December 2024
46. RUBIN R
    In Search of COVID-19 Vaccines That Elicit Mucosal Immunity and Stop Transmission.
    JAMA. 2024 Dec 20. doi: 10.1001/jama.2024.23627.
    PubMed    
    
    
    
47. GENG LN, Erlandson KM, Hornig M, Letts R, et al
    2024 Update of the RECOVER-Adult Long COVID Research Index.
    JAMA. 2024 Dec 18. doi: 10.1001/jama.2024.24184.
    PubMed     Abstract available
    
    
    
48. ANDERER S
    New Research Suggests Increased Risk of Some Autoimmune Disorders After COVID-19.
    JAMA. 2024 Dec 13. doi: 10.1001/jama.2024.24894.
    PubMed    
    
    
    
49. ANDERER S
    Trial Shows It's Safe to Get COVID-19, Flu Vaccines at the Same Time.
    JAMA. 2024 Dec 13. doi: 10.1001/jama.2024.24891.
    PubMed    
    
    
    
50. MAIA IS, Kawano-Dourado L, Tramujas L, de Oliveira NE, et al
    High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure: The RENOVATE Randomized Clinical Trial.
    JAMA. 2024 Dec 10. doi: 10.1001/jama.2024.26244.
    PubMed     Abstract available
    
    
    
51. ANDERER S
    CDC Recommends Second COVID-19 Vaccine Dose for Older Adults.
    JAMA. 2024 Dec 6. doi: 10.1001/jama.2024.24258.
    PubMed    
    
    
    November 2024
52. RUBIN R
    What to Know About XEC, the New SARS-CoV-2 Variant Expected to Dominate Winter's COVID-19 Wave.
    JAMA. 2024 Nov 22. doi: 10.1001/jama.2024.24481.
    PubMed    
    
    
    
53. ANDERER S
    Early COVID-19 Infections Linked With Higher Heart Attack, Stroke Risk.
    JAMA. 2024 Nov 15. doi: 10.1001/jama.2024.23045.
    PubMed    
    
    
    
54. ANDERER S
    FDA Authorizes First At-Home COVID-19 and Flu Combo Test.
    JAMA. 2024 Nov 8. doi: 10.1001/jama.2024.22561.
    PubMed    
    
    
    October 2024
55. TADROUS M, Callaway Kim K, Hernandez I, Rothenberger SD, et al
    Differences in Drug Shortages in the US and Canada.
    JAMA. 2024 Oct 31. doi: 10.1001/jama.2024.17688.
    PubMed     Abstract available
    
    
    
56. ANDERER S
    HHS Will Provide Free US-Made COVID-19 Tests to Households.
    JAMA. 2024 Oct 25. doi: 10.1001/jama.2024.21819.
    PubMed    
    
    
    
57. 
    Audio Highlights: September 14-20, 2024.
    JAMA. 2024;332:e2318402.
    PubMed    
    
    
    
58. HABIB AR, Ijaz N
    Public Health Crisis in Gaza-Reply.
    JAMA. 2024;332:1305-1306.
    PubMed    
    
    
    
59. PATEL P, Wentworth DE, Daskalakis D
    COVID-19 Therapeutics for Nonhospitalized Older Adults.
    JAMA. 2024 Oct 7. doi: 10.1001/jama.2024.16460.
    PubMed    
    
    
    September 2024
60. ANDERER S
    Caseload Strain Contributed to 1 in 5 COVID-19 Deaths at US Hospitals.
    JAMA. 2024 Sep 27. doi: 10.1001/jama.2024.19687.
    PubMed    
    
    
    
61. ANDERER S
    FDA Approves Updated COVID-19 Vaccines.
    JAMA. 2024 Sep 20. doi: 10.1001/jama.2024.19127.
    PubMed    
    
    
    
62. LIM JK, Ramgopal S, Hoffmann JA, Lorenz D, et al
    Characteristics and Trends of Prehospital Encounters for Opioid Overdoses Among US Youth, 2018-2022.
    JAMA. 2024 Sep 18:e2417341. doi: 10.1001/jama.2024.17341.
    PubMed    
    
    
    
63. AMBA V, Cooper MSL, Sommers BD
    History Repeats-The Election Battle for Medicaid in 2024.
    JAMA. 2024;332:867-868.
    PubMed    
    
    
    
64. VAUGHN VM, Dickson RP, Horowitz JK, Flanders SA, et al
    Community-Acquired Pneumonia: A Review.
    JAMA. 2024 Sep 16. doi: 10.1001/jama.2024.14796.
    PubMed     Abstract available
    
    
    
65. ANDERER S
    Combo COVID-19 and Flu mRNA Vaccine Falls Short of Total Flu Protection.
    JAMA. 2024 Sep 13. doi: 10.1001/jama.2024.18194.
    PubMed    
    
    
    
66. BOCK A
    New Guidance Helps Clinicians Use Pemivibart to Protect Immunocompromised Patients From COVID-19.
    JAMA. 2024 Sep 13. doi: 10.1001/jama.2024.18589.
    PubMed    
    
    
    
67. ANDERER S
    CDC: Overall Deaths, Especially From COVID-19, Lower in 2023.
    JAMA. 2024 Sep 6. doi: 10.1001/jama.2024.17606.
    PubMed    
    
    
    
68. RUBIN R
    The Latest Research About Paxlovid: Effectiveness, Access, and Possible Long COVID Benefits.
    JAMA. 2024 Sep 6. doi: 10.1001/jama.2024.16432.
    PubMed    
    
    
    
69. SURIE D, Self WH, Zhu Y, Yuengling KA, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and Older.
    JAMA. 2024 Sep 4:e2415775. doi: 10.1001/jama.2024.15775.
    PubMed    
    
    
    
70. 
    Audio Highlights.
    JAMA. 2024;332:e2318388.
    PubMed    
    
    
    August 2024
71. WOOLF SH
    Increasing Mortality Rates in the US, but Not From COVID-19.
    JAMA. 2024 Aug 29. doi: 10.1001/jama.2024.13626.
    PubMed    
    
    
    
72. SEMENZATO L, Le Vu S, Botton J, Bertrand M, et al
    Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies.
    JAMA. 2024 Aug 26:e2416380. doi: 10.1001/jama.2024.16380.
    PubMed     Abstract available
    
    
    
73. ANDERER S
    Widespread SARS-CoV-2 Exposure Among Wildlife in the US.
    JAMA. 2024 Aug 23. doi: 10.1001/jama.2024.15877.
    PubMed    
    
    
    
74. GROSS RS, Thaweethai T, Kleinman LC, Snowden JN, et al
    Characterizing Long COVID in Children and Adolescents.
    JAMA. 2024 Aug 21:e2412747. doi: 10.1001/jama.2024.12747.
    PubMed     Abstract available
    
    
    
75. AHMAD FB, Cisewski JA, Anderson RN
    Leading Causes of Death in the US, 2019-2023.
    JAMA. 2024 Aug 8. doi: 10.1001/jama.2024.15563.
    PubMed    
    
    
    
76. WARE LB, Files DC, Fowler A, Aboodi MS, et al
    Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial.
    JAMA. 2024;332:390-400.
    PubMed     Abstract available
    
    
    
77. HARRIS E
    NIH Starts Testing Nasal COVID-19 Vaccine in US.
    JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.13769.
    PubMed    
    
    
    July 2024
78. HARRIS E
    COVID-19 Vaccination in Early Pregnancy Not Linked to Birth Defects.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13389.
    PubMed    
    
    
    
79. YOUMSHAJEKIAN L
    COVID-19 May Protect Against the Common Cold-Here's Why Knowing That Could Lead to Better Vaccines.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13382.
    PubMed    
    
    
    
80. AGARWAL SD, Cook BL, Liebman JB
    Effect of Cash Benefits on Health Care Utilization and Health: A Randomized Study.
    JAMA. 2024 Jul 22:e2413004. doi: 10.1001/jama.2024.13004.
    PubMed     Abstract available
    
    
    
81. FRIEDL N, Sporreiter M, Winkler C, Heublein A, et al
    Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection.
    JAMA. 2024 Jul 15:e2411174. doi: 10.1001/jama.2024.11174.
    PubMed    
    
    
    
82. HARRIS E
    Symptoms After COVID-19 Vaccination Tied to Higher Antibody Levels.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12231.
    PubMed    
    
    
    
83. RUBIN R
    Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.10992.
    PubMed    
    
    
    
84. HARRIS E
    Review Calls for Standardized Long COVID Definition.
    JAMA. 2024;332:97.
    PubMed    
    
    
    
85. FANG Z, Ahrnsbrak R, Rekito A
    Evidence Mounts That About 7% of US Adults Have Had Long COVID.
    JAMA. 2024;332:5-6.
    PubMed    
    
    
    June 2024
86. ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al
    Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults.
    JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673.
    PubMed    
    
    
    
87. PIRRACCHIO R, Venkatesh B, Legrand M
    Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review.
    JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.6096.
    PubMed     Abstract available
    
    
    
88. ABDUL-AZIZ MH, Hammond NE, Brett SJ, Cotta MO, et al
    Prolonged vs Intermittent Infusions of beta-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.
    JAMA. 2024 Jun 12:e249803. doi: 10.1001/jama.2024.9803.
    PubMed     Abstract available
    
    
    
89. DEAN N, Amin AB
    Test-Negative Study Designs for Evaluating Vaccine Effectiveness.
    JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.5633.
    PubMed    
    
    
    
90. VAN DER LINDEN S, Roozenbeek J
    "Inoculation" to Resist Misinformation.
    JAMA. 2024;331:1961-1962.
    PubMed    
    
    
    
91. ANGUS DC, Huang AJ, Lewis RJ, Abernethy AP, et al
    The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided.
    JAMA. 2024 Jun 3. doi: 10.1001/jama.2024.4088.
    PubMed     Abstract available
    
    
    May 2024
92. HARRIS E
    Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8628.
    PubMed    
    
    
    
93. HARRIS E
    Lower Dose of Mpox Vaccine Was Safe, Effective.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
    PubMed    
    
    
    
94. HARRIS E
    Microneedle Vaccine Patches Generated Immune Response in Children.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8629.
    PubMed    
    
    
    
95. BOCK A
    Researchers See Hope in Symptom-Guided Exercise for Long COVID With Postexertional Malaise.
    JAMA. 2024;331:1609-1611.
    PubMed    
    
    
    
96. DEVEREUX G, Cotton S, Nath M, McMeekin N, et al
    Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.
    JAMA. 2024 May 19. doi: 10.1001/jama.2024.8771.
    PubMed     Abstract available
    
    
    
97. RUBIN R
    Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370.
    PubMed    
    
    
    
98. XIE Y, Choi T, Al-Aly Z
    Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024.
    JAMA. 2024 May 15:e247395. doi: 10.1001/jama.2024.7395.
    PubMed    
    
    
    
99. 
    Audio Highlights.
    JAMA. 2024;331:e2318283.
    PubMed    
    
    
    
100. WEN X, Yan J, Zhu Z
     Apixaban to Prevent Recurrence After Cryptogenic Stroke.
     JAMA. 2024 May 13. doi: 10.1001/jama.2024.6848.
     PubMed    
     
     
     
101. HARRIS E
     National Academies Report: COVID-19 Vaccines Don't Cause Many Potential Harms.
     JAMA. 2024 May 10. doi: 10.1001/jama.2024.7724.
     PubMed    
     
     
     
102. HARRIS E
     Trials Will Evaluate Treatments for Long COVID Nervous System Problems.
     JAMA. 2024;331:1439-1440.
     PubMed    
     
     
     
103. AGRAWAL S, Ross JS, Ramachandran R
     Implications for Public Health Regulation if Chevron Deference Is Overturned.
     JAMA. 2024;331:1443-1444.
     PubMed    
     
     
     
104. CHESHIRE WP, Dudenkov DV, Munipalli B
     Tilt Table Testing.
     JAMA. 2024;331:1494-1495.
     PubMed    
     
     
     April 2024
105. HARRIS E
     WHO Launches Broad Coronavirus Surveillance Network.
     JAMA. 2024 Apr 26. doi: 10.1001/jama.2024.6724.
     PubMed    
     
     
     
106. ALLEN MR, Desai N, Namazi A, Leas E, et al
     Characteristics of X (Formerly Twitter) Community Notes Addressing COVID-19 Vaccine Misinformation.
     JAMA. 2024 Apr 24:e244800. doi: 10.1001/jama.2024.4800.
     PubMed    
     
     
     
107. HARRIS E
     Meta-Analysis: "Limited" Benefits to Rapid Viral Tests in EDs.
     JAMA. 2024;331:1355.
     PubMed    
     
     
     
108. HARRIS E
     Deaths From Excessive Drinking Rose in the US During Pandemic.
     JAMA. 2024;331:1355.
     PubMed    
     
     
     
109. IMPERIALE TF, Lavin P, Ransohoff DF
     Multitarget Stool RNA Testing.
     JAMA. 2024;331:1418.
     PubMed    
     
     
     
110. BAIRD G
     Multitarget Stool RNA Testing.
     JAMA. 2024;331:1418-1419.
     PubMed    
     
     
     
111. BARNELL EK, Lieberman DA
     Multitarget Stool RNA Testing-Reply.
     JAMA. 2024;331:1419-1420.
     PubMed    
     
     
     
112. HARRIS E
     Antidepressant Prescriptions for Female Teens Surged After Pandemic.
     JAMA. 2024;331:1266.
     PubMed    
     
     
     
113. HARRIS E
     COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
     JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
     PubMed    
     
     
     
114. ANDERER S
     Could "Empathetic Refutation" Help Clinicians Sway Vaccine Skeptics?
     JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
     PubMed    
     
     
     
115. DAWOOD FS, Payne AB, McMorrow ML
     Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus.
     JAMA. 2024 Apr 11. doi: 10.1001/jama.2024.5859.
     PubMed    
     
     
     
116. ANDERER S
     Study: 1 of Every 9 US Cancer Cases Missed During 2020 Pandemic.
     JAMA. 2024;331:1082.
     PubMed    
     
     
     
117. GUSSIN GM, McKinnell JA, Singh RD, Miller LG, et al
     Reducing Hospitalizations and Multidrug-Resistant Organisms via Regional Decolonization in Hospitals and Nursing Homes.
     JAMA. 2024 Apr 1:e242759. doi: 10.1001/jama.2024.2759.
     PubMed     Abstract available
     
     
     March 2024
118. HARRIS E
     COVID-19 Infection Tied to Slight Cognitive Deficits.
     JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2087.
     PubMed    
     
     
     
119. HARRIS E
     COVID-19 Associated With Higher Risk of Autoimmune Diseases.
     JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2092.
     PubMed    
     
     
     
120. LU Y, Matuska K, Nadimpalli G, Ma Y, et al
     Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults.
     JAMA. 2024;331:938-950.
     PubMed     Abstract available
     
     
     
121. NIELSEN FM, Klitgaard TL, Siegemund M, Laake JH, et al
     Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial.
     JAMA. 2024 Mar 19:e242934. doi: 10.1001/jama.2024.2934.
     PubMed     Abstract available
     
     
     
122. SCHWARTZSTEIN RM
     Oxygen Supplementation in COVID-19-How Much Is Enough?
     JAMA. 2024 Mar 19. doi: 10.1001/jama.2024.2935.
     PubMed    
     
     
     
123. HARRIS E
     CDC Tracking BA.2.87.1, New Omicron Subvariant With Potential to Evade Immunity.
     JAMA. 2024;331:907.
     PubMed    
     
     
     
124. ANDERER S
     CDC Recommends Additional COVID-19 Booster for Older Adults.
     JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2071.
     PubMed    
     
     
     
125. MCKENZIE C, Moore L, Borthwick M
     Vitamin C for Patients Hospitalized With COVID-19.
     JAMA. 2024;331:886.
     PubMed    
     
     
     
126. ADHIKARI NKJ, Lamontagne F
     Vitamin C for Patients Hospitalized With COVID-19-Reply.
     JAMA. 2024;331:886-887.
     PubMed    
     
     
     
127. HARRIS E
     Virtual Group Exercise Program Improved Long COVID Symptoms.
     JAMA. 2024;331:822.
     PubMed    
     
     
     
128. HARRIS E
     Better Outcomes When Kidney Damage Is From COVID-19.
     JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1574.
     PubMed    
     
     
     
129. HARRIS E
     HPV Vaccination Rates Stagnated During COVID-19 Pandemic.
     JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1569.
     PubMed    
     
     
     
130. HARRIS E
     Millions of US Children Experience Range of Long COVID Effects.
     JAMA. 2024;331:726.
     PubMed    
     
     
     February 2024
131. ANDERSSON NW, Thiesson EM, Hviid A
     Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
     JAMA. 2024 Feb 26:e241036. doi: 10.1001/jama.2024.1036.
     PubMed    
     
     
     
132. HARRIS E
     New Antiviral on the Horizon for Mild to Moderate COVID-19.
     JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0729.
     PubMed    
     
     
     
133. GRAETZ N, Hepburn P, Gershenson C, Porter SR, et al
     Examining Excess Mortality Associated With the COVID-19 Pandemic for Renters Threatened With Eviction.
     JAMA. 2024;331:592-600.
     PubMed     Abstract available
     
     
     
134. RUBIN R
     When It Comes to SARS-CoV-2 Clearance, People Who are Immunocompromised Are Not All Alike.
     JAMA. 2024 Feb 14. doi: 10.1001/jama.2024.1014.
     PubMed    
     
     
     
135. NORMAN M, Magnus MC, Soderling J, Juliusson PB, et al
     Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
     JAMA. 2024;331:396-407.
     PubMed     Abstract available
     
     
     
136. FELDSTEIN LR, Britton A, Grant L, Wiegand R, et al
     Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
     JAMA. 2024;331:408-416.
     PubMed     Abstract available
     
     
     January 2024
137. HARRIS E
     Missed Vaccine Doses Tied to Worse COVID-19 Outcomes.
     JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28340.
     PubMed    
     
     
     
138. RUBIN R
     Paxlovid Is Effective but Underused-Here's What the Latest Research Says About Rebound and More.
     JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28254.
     PubMed    
     
     
     
139. RUBIN R
     As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2 "Variant of Interest".
     JAMA. 2024 Jan 12. doi: 10.1001/jama.2023.27841.
     PubMed    
     
     
     
140. RUBIN R
     From "Immunity Debt" to "Immunity Theft"-How COVID-19 Might Be Tied to Recent Respiratory Disease Surges.
     JAMA. 2024 Jan 10. doi: 10.1001/jama.2023.26608.
     PubMed    
     
     
     
141. KAPOOR N, Dietz C, Buettner BP
     An Incarcerated Individual With Weight Loss and Interstitial Pulmonary Infiltrates.
     JAMA. 2024 Jan 8. doi: 10.1001/jama.2023.24260.
     PubMed    
     
     
     
142. MARKS P, Califf R
     Is Vaccination Approaching a Dangerous Tipping Point?
     JAMA. 2024 Jan 5. doi: 10.1001/jama.2023.27685.
     PubMed    
     
     
     
143. HARRIS E
     Long COVID in Nursing Home Residents Manifests as Functional Decline.
     JAMA. 2024;331:15.
     PubMed    
     
     
     December 2023
144. HARRIS E
     Disproportionate Death Rates Reported in US Prisons Early in the COVID-19 Pandemic.
     JAMA. 2023 Dec 27. doi: 10.1001/jama.2023.25770.
     PubMed    
     
     
     
145. HARRIS E
     Using Throat Swabs Improved Sensitivity in Detecting SARS-CoV-2.
     JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25267.
     PubMed    
     
     
     
146. HARRIS E
     Program Offering Free COVID-19 and Flu Services Expands Nationwide.
     JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25268.
     PubMed    
     
     
     
147. HARRIS E
     Life Expectancy in US Climbed After Declines Related to COVID-19.
     JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24683.
     PubMed    
     
     
     
148. SURAN M
     Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID.
     JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24103.
     PubMed    
     
     
     
149. RUBIN R
     Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines.
     JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.0644.
     PubMed    
     
     
     
150. MATHEW P, Feldmann M
     Treatment of Adults Hospitalized With COVID-19 Pneumonia.
     JAMA. 2023;330:2122-2123.
     PubMed    
     
     
     
151. POWDERLY WG, LaVange L, Bozzette SA
     Treatment of Adults Hospitalized With COVID-19 Pneumonia-Reply.
     JAMA. 2023;330:2123.
     PubMed    
     
     
     
152. SCHMIDT M, Hajage D, Lebreton G, Dres M, et al
     Prone Positioning During Extracorporeal Membrane Oxygenation in Patients With Severe ARDS: The PRONECMO Randomized Clinical Trial.
     JAMA. 2023 Dec 1. doi: 10.1001/jama.2023.24491.
     PubMed     Abstract available
     
     
     November 2023
153. EASTMAN Q
     Study Shows Businesses Selling Unapproved Stem Cell Treatments Have Turned to Long COVID.
     JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23897.
     PubMed    
     
     
     
154. BERGMAN C
     Treatment of SARS-CoV-2 Infection in US Nursing Homes.
     JAMA. 2023;330:2021-2022.
     PubMed    
     
     
     
155. MCGARRY BE, Sommers BD, Barnett ML
     Treatment of SARS-CoV-2 Infection in US Nursing Homes-Reply.
     JAMA. 2023;330:2022.
     PubMed    
     
     
     
156. HARRIS E
     COVID Moonshot Drove Discovery of Potential COVID-19 Antivirals.
     JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22934.
     PubMed    
     
     
     
157. HARRIS E
     Smell, Taste Issues After Mild COVID-19 Resolve Over 3 Years.
     JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22930.
     PubMed    
     
     
     
158. HARRIS E
     Long COVID Linked With Viral Persistence, Serotonin Decline.
     JAMA. 2023;330:1827.
     PubMed    
     
     
     
159. HARRIS E
     Audit Finds US National Stockpile "Was Not Equipped" for the Pandemic.
     JAMA. 2023;330:1828.
     PubMed    
     
     
     
160. STEWART TG, Rebolledo PA, Mourad A, Lindsell CJ, et al
     Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
     JAMA. 2023 Nov 17:e2323363. doi: 10.1001/jama.2023.23363.
     PubMed     Abstract available
     
     
     
161. HARRIS E
     Combined COVID-19, Flu Vaccine Candidate Headed to Phase 3 Trials.
     JAMA. 2023 Nov 15. doi: 10.1001/jama.2023.22353.
     PubMed    
     
     
     
162. HARRIS E
     Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS.
     JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21872.
     PubMed    
     
     
     
163. HARRIS E
     HRSA Study: US Abortions Decreased 14% During COVID-19.
     JAMA. 2023 Nov 1. doi: 10.1001/jama.2023.21178.
     PubMed    
     
     
     October 2023
164. ADHIKARI NKJ, Hashmi M, Tirupakuzhi Vijayaraghavan BK, Haniffa R, et al
     Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
     JAMA. 2023 Oct 25:e2321407. doi: 10.1001/jama.2023.21407.
     PubMed     Abstract available
     
     
     
165. JABALEY CS, Coopersmith CM
     Vitamin C for Patients With COVID-19: More Evidence of Lack of Efficacy in Patients With Sepsis.
     JAMA. 2023 Oct 25. doi: 10.1001/jama.2023.18592.
     PubMed    
     
     
     
166. HARRIS E
     US Survey: About 7% of Adults, 1% of Children Have Had Long COVID.
     JAMA. 2023;330:1516.
     PubMed    
     
     
     
167. HARRIS E
     COVID-19 Hospitalizations Up Among Older Adults.
     JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19796.
     PubMed    
     
     
     
168. HARRIS E
     Previous COVID-19 Linked With Autoimmune Conditions.
     JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19798.
     PubMed    
     
     
     
169. BATRA A, Nath A, Koralnik IJ
     Postacute Sequelae of SARS-CoV-2 Infection.
     JAMA. 2023;330:1491-1492.
     PubMed    
     
     
     
170. THAWEETHAI T, Foulkes AS
     Postacute Sequelae of SARS-CoV-2 Infection-Reply.
     JAMA. 2023;330:1492.
     PubMed    
     
     
     
171. HARRIS E
     Exercise Programs Might Improve Long COVID.
     JAMA. 2023;330:1421.
     PubMed    
     
     
     
172. SIEGAL DM, Belley-Cote EP, Lee SF, Hill S, et al
     Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care: The STRATUS Randomized Clinical Trial.
     JAMA. 2023 Oct 12. doi: 10.1001/jama.2023.20820.
     PubMed     Abstract available
     
     
     
173. RAASVELD SJ, de Bruin S, Reuland MC, van den Oord C, et al
     Red Blood Cell Transfusion in the Intensive Care Unit.
     JAMA. 2023 Oct 12. doi: 10.1001/jama.2023.20737.
     PubMed     Abstract available
     
     
     
174. HARRIS E
     Changes in SARS-CoV-2 Sequence Linked With Antiviral Use.
     JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19202.
     PubMed    
     
     
     September 2023
175. CHEW KW, Malani PN, Gandhi RT
     COVID-19 Therapeutics for Nonhospitalized Patients-Updates and Future Directions.
     JAMA. 2023 Sep 29. doi: 10.1001/jama.2023.19542.
     PubMed    
     
     
     
176. HARRIS E
     Some People Still Have Long COVID Symptoms After 2 Years.
     JAMA. 2023;330:1127.
     PubMed    
     
     
     
177. RUBIN R
     Updated COVID-19 Vaccine Now Available in US, Recommended for Everyone Older Than 6 Months.
     JAMA. 2023 Sep 18. doi: 10.1001/jama.2023.19759.
     PubMed    
     
     
     
178. TARTOF SY, Frankland TB, Slezak JM, Puzniak L, et al
     Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years.
     JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.17473.
     PubMed    
     
     
     
179. DEL RIO C, Malani PN
     COVID-19 in the Fall of 2023-Forgotten but Not Gone.
     JAMA. 2023 Sep 12. doi: 10.1001/jama.2023.19049.
     PubMed    
     
     
     
180. HARRIS E
     Two New Analyses Add to Long COVID Understanding.
     JAMA. 2023;330:905-906.
     PubMed    
     
     
     
181. LUGAR M, Eugster A, Achenbach P, von dem Berge T, et al
     SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood.
     JAMA. 2023 Sep 8. doi: 10.1001/jama.2023.16348.
     PubMed     Abstract available
     
     
     
182. HARRIS E
     High Blood Pressure More Likely After COVID-19 Than Flu.
     JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16676.
     PubMed    
     
     
     
183. HARRIS E
     HHS To Invest $1.4 Billion in New COVID-19 Vaccines, Therapies.
     JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16678.
     PubMed    
     
     
     
184. HARRIS E
     Federal Government Announces Long COVID Trials, Research Office.
     JAMA. 2023;330:797.
     PubMed    
     
     
     
185. KENTISH-BARNES N, Resche-Rigon M, Lafarge A, Souppart V, et al
     PTSD Symptoms Among Family Members of Patients With ARDS Caused by COVID-19 After 12 Months.
     JAMA. 2023 Sep 1. doi: 10.1001/jama.2023.15879.
     PubMed    
     
     
     August 2023
186. HARRIS E
     Severe COVID-19 Linked to Enduring Immune System Changes.
     JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16109.
     PubMed    
     
     
     
187. HARRIS E
     CDC Assesses Risk From BA.2.86, Highly Mutated COVID-19 Variant.
     JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16105.
     PubMed    
     
     
     
188. HARRIS E
     Lung Transplants for COVID-19 Similarly Successful.
     JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.15450.
     PubMed    
     
     
     
189. YOO SGK, Chung GS, Bahendeka SK, Sibai AM, et al
     Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries.
     JAMA. 2023;330:715-724.
     PubMed     Abstract available
     
     
     
190. ABBASI J
     What to Know About EG.5, the Latest SARS-CoV-2 "Variant of Interest".
     JAMA. 2023 Aug 18. doi: 10.1001/jama.2023.16498.
     PubMed    
     
     
     
191. RAGLOW Z, Malani PN, Petty LA
     Outpatient Treatment for COVID-19.
     JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.16666.
     PubMed    
     
     
     
192. RUBIN R
     Why Blood Type Seems to Be Linked With COVID-19 Risk.
     JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.15996.
     PubMed    
     
     
     
193. DOS SANTOS RAS, Taccone FS, Annoni F
     Renin-Angiotensin System Modulation in Adults With COVID-19.
     JAMA. 2023;330:663-664.
     PubMed    
     
     
     
194. SELF WH, DeClercq J, Orr M
     Renin-Angiotensin System Modulation in Adults With COVID-19-Reply.
     JAMA. 2023;330:664-665.
     PubMed    
     
     
     
195. HARRIS E
     Case of Middle East Respiratory Syndrome Coronavirus Confirmed.
     JAMA. 2023 Aug 2. doi: 10.1001/jama.2023.13618.
     PubMed    
     
     
     
196. ABBASI J
     A Genetic Explanation for Why Some People Had Asymptomatic COVID-19.
     JAMA. 2023 Aug 2. doi: 10.1001/jama.2023.14703.
     PubMed    
     
     
     
197. DAVIDSON BL, Levi MM
     Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
     JAMA. 2023;330:471-472.
     PubMed    
     
     
     
198. GOLIGHER EC, Lawler PR, Zarychanski R
     Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19-Reply.
     JAMA. 2023;330:472-473.
     PubMed    
     
     
     July 2023
199. SURAN M
     HHS Urges Primary Care Clinicians to Help Patients Manage Long COVID's Mental Health Symptoms.
     JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13605.
     PubMed    
     
     
     
200. HARRIS E
     Free COVID-19 Vaccinations on the Way for Uninsured Adults.
     JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13133.
     PubMed    
     
     
     
201. GLEASON JL, Tamburro R, Signore C
     Promoting Data Harmonization of COVID-19 Research in Pregnant and Pediatric Populations.
     JAMA. 2023 Jul 20. doi: 10.1001/jama.2023.10835.
     PubMed    
     
     
     
202. MCGARRY BE, Sommers BD, Wilcock AD, Grabowski DC, et al
     Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US Nursing Homes.
     JAMA. 2023 Jul 14:e2312945. doi: 10.1001/jama.2023.12945.
     PubMed    
     
     
     
203. O'HALLORAN JA, Ko ER, Anstrom KJ, Kedar E, et al
     Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
     JAMA. 2023 Jul 10:e2311043. doi: 10.1001/jama.2023.11043.
     PubMed     Abstract available
     
     
     
204. RUBIN R
     This Fall's COVID-19 Vaccines Will Target Omicron XBB Subvariants, but Who Needs Them Remains to Be Seen.
     JAMA. 2023 Jul 5. doi: 10.1001/jama.2023.10053.
     PubMed    
     
     
     June 2023
205. HARRIS E
     Patients With COVID-19 and Fungal Infections Had High Mortality Rates.
     JAMA. 2023 Jun 28. doi: 10.1001/jama.2023.11957.
     PubMed    
     
     
     
206. MICHAELS D, Wagner GR, Ryan L
     Lessons From COVID-19 for Protecting Workers in the Next Pandemic.
     JAMA. 2023 Jun 16. doi: 10.1001/jama.2023.8229.
     PubMed    
     
     
     
207. ANDREWS N, Stowe J, Miller E, Ramsay M, et al
     BA.1 Bivalent COVID-19 Vaccine Use and Stroke in England.
     JAMA. 2023 Jun 15. doi: 10.1001/jama.2023.10123.
     PubMed    
     
     
     
208. HARRIS E
     Hybrid COVID-19 Immunity Common by Fall of 2022.
     JAMA. 2023 Jun 14. doi: 10.1001/jama.2023.10399.
     PubMed    
     
     
     
209. LANDON E
     An Apple a Day.
     JAMA. 2023 Jun 8. doi: 10.1001/jama.2023.8957.
     PubMed    
     
     
     
210. HARRIS E
     FDA Grants Full Approval to Paxlovid, COVID-19 Antiviral Treatment.
     JAMA. 2023 Jun 7. doi: 10.1001/jama.2023.9925.
     PubMed    
     
     
     
211. DAHNE J, Hawk LW Jr
     Health Equity and Decentralized Trials.
     JAMA. 2023 Jun 1. doi: 10.1001/jama.2023.6982.
     PubMed    
     
     
     May 2023
212. GROSS R, Lo Re V 3rd
     Disentangling the Postacute Sequelae of SARS-CoV-2: E Unibus Pluram (From One, Many).
     JAMA. 2023 May 25. doi: 10.1001/jama.2023.8961.
     PubMed    
     
     
     
213. THAWEETHAI T, Jolley SE, Karlson EW, Levitan EB, et al
     Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
     JAMA. 2023 May 25:e238823. doi: 10.1001/jama.2023.8823.
     PubMed     Abstract available
     
     
     
214. HARRIS E
     CDC Updates COVID-19 Data Reporting as US Public Health Emergency Ends.
     JAMA. 2023 May 24. doi: 10.1001/jama.2023.9150.
     PubMed    
     
     
     
215. WEISS A, Donnachie E, Beyerlein A, Ziegler AG, et al
     Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19.
     JAMA. 2023 May 22:e238674. doi: 10.1001/jama.2023.8674.
     PubMed    
     
     
     
216. HARRIS E
     WHO Declares End of COVID-19 Global Health Emergency.
     JAMA. 2023 May 17. doi: 10.1001/jama.2023.8656.
     PubMed    
     
     
     
217. HARRIS E
     COVID-19 Vaccine and Health Care Visits for Menstrual Changes.
     JAMA. 2023 May 17. doi: 10.1001/jama.2023.8658.
     PubMed    
     
     
     
218. ASHRAF S, Ashraf N
     Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19.
     JAMA. 2023;329:1702.
     PubMed    
     
     
     
219. MCCARTHY MW, Lindsell CJ, Naggie S
     Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19-Reply.
     JAMA. 2023;329:1702-1703.
     PubMed    
     
     
     
220. MARCUS R
     New Alzheimer Disease Drugs, Long COVID and the Central Nervous System, and a Nasal Spray for Migraines-Highlights From the 2023 American Academy of Neurology Conference.
     JAMA. 2023 May 10. doi: 10.1001/jama.2023.4389.
     PubMed    
     
     
     
221. HARRIS E
     BCG Vaccine Not Effective Against COVID-19.
     JAMA. 2023 May 3. doi: 10.1001/jama.2023.7763.
     PubMed    
     
     
     
222. HARRIS E
     XBB.1.16 Deemed COVID-19 "Variant of Interest".
     JAMA. 2023 May 3. doi: 10.1001/jama.2023.7768.
     PubMed    
     
     
     
223. LANDHUIS EW
     How Primary Care Physicians Can Recognize and Treat Long COVID.
     JAMA. 2023 May 3. doi: 10.1001/jama.2023.6604.
     PubMed    
     
     
     
224. BOHRMANN B, Massa MS, Ross S, Lewington S, et al
     Body Mass Index and Risk of Hospitalization or Death Due to Lower or Upper Respiratory Tract Infection.
     JAMA. 2023;329:1512-1514.
     PubMed    
     
     
     
225. BOMMERSBACH TJ, McKean AJ, Olfson M, Rhee TG, et al
     National Trends in Mental Health-Related Emergency Department Visits Among Youth, 2011-2020.
     JAMA. 2023;329:1469-1477.
     PubMed     Abstract available
     
     
     April 2023
226. HARRIS E
     FDA Simplifies COVID-19 Vaccination, Permits Some Additional Doses.
     JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6624.
     PubMed    
     
     
     
227. HARRIS E
     How Parents' Views Are Tied to Children's COVID-19 Vaccination.
     JAMA. 2023 Apr 19. doi: 10.1001/jama.2023.6292.
     PubMed    
     
     
     
228. SPUNGEN H, Burton J, Schenkel S, Schriger DL, et al
     Completeness and Spin of medRxiv Preprint and Associated Published Abstracts of COVID-19 Randomized Clinical Trials.
     JAMA. 2023;329:1310-1312.
     PubMed    
     
     
     
229. HARRIS E
     Updated WHO Guidance for Prioritizing COVID-19 Vaccines.
     JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6256.
     PubMed    
     
     
     
230. LEE MMY, McMurray JJV
     Lack of Benefit of Renin-Angiotensin System Inhibitors in COVID-19.
     JAMA. 2023;329:1155-1156.
     PubMed    
     
     
     
231. SELF WH, Shotwell MS, Gibbs KW, de Wit M, et al
     Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.
     JAMA. 2023;329:1170-1182.
     PubMed     Abstract available
     
     
     
232. LAWLER PR, Derde LPG, van de Veerdonk FL, McVerry BJ, et al
     Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
     JAMA. 2023;329:1183-1196.
     PubMed     Abstract available
     
     
     
233. XIE Y, Choi T, Al-Aly Z
     Risk of Death in Patients Hospitalized for COVID-19 vs Seasonal Influenza in Fall-Winter 2022-2023.
     JAMA. 2023 Apr 6. doi: 10.1001/jama.2023.5348.
     PubMed    
     
     
     
234. HARRIS E
     Study: US COVID-19 Outcomes Tied to State Characteristics and Policies.
     JAMA. 2023 Apr 5. doi: 10.1001/jama.2023.5622.
     PubMed    
     
     
     
235. AMMIRATI E, Moslehi JJ
     Diagnosis and Treatment of Acute Myocarditis: A Review.
     JAMA. 2023;329:1098-1113.
     PubMed     Abstract available
     
     
     
236. HARRIS E
     Public Had Most Trust in Advice From Physicians, Nurses During Pandemic.
     JAMA. 2023;329:1053.
     PubMed    
     
     
     
237. HARRIS E
     "Living" Systematic Review of Mental Health During Pandemic.
     JAMA. 2023;329:1054.
     PubMed    
     
     
     
238. ESMAIL LC, Kapp P, Assi R, Wood J, et al
     Sharing of Individual Patient-Level Data by Trialists of Randomized Clinical Trials of Pharmacological Treatments for COVID-19.
     JAMA. 2023 Apr 3:e234590. doi: 10.1001/jama.2023.4590.
     PubMed    
     
     
     March 2023
239. HARRIS E
     Cold Virus Provided Cross-reactivity Against SARS-CoV-2 in Children.
     JAMA. 2023 Mar 29. doi: 10.1001/jama.2023.5261.
     PubMed    
     
     
     
240. CAMPO R
     Illness Metaphors and COVID-19.
     JAMA. 2023;329:1035.
     PubMed    
     
     
     
241. HARRIS E
     Nasally Administered Monoclonal Antibody for COVID-19.
     JAMA. 2023 Mar 22. doi: 10.1001/jama.2023.4000.
     PubMed    
     
     
     
242. GOLIGHER EC, Lawler PR, Jensen TP, Talisa V, et al
     Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
     JAMA. 2023 Mar 21. doi: 10.1001/jama.2023.3651.
     PubMed     Abstract available
     
     
     
243. LONDON AJ, Seymour CW
     The Ethics of Clinical Research: Managing Persistent Uncertainty.
     JAMA. 2023;329:884-885.
     PubMed    
     
     
     
244. COKER TR, Cheng TL, Ybarra M
     Addressing the Long-term Effects of the COVID-19 Pandemic on Children and Families: A Report From the National Academies of Sciences, Engineering, and Medicine.
     JAMA. 2023 Mar 16. doi: 10.1001/jama.2023.4371.
     PubMed    
     
     
     
245. HARRIS E
     FDA Approves First Over-the-counter Combined COVID-19 and Flu Test.
     JAMA. 2023 Mar 8. doi: 10.1001/jama.2023.3192.
     PubMed    
     
     
     
246. SURAN M
     Long COVID Linked With Unemployment in New Analysis.
     JAMA. 2023;329:701-702.
     PubMed    
     
     
     
247. RUBIN R
     Highlights From CROI, the Conference on Retroviruses and Opportunistic Infections-Postexposure Prophylaxis for Sexually Transmitted Infections, a New Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More.
     JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.0158.
     PubMed    
     
     
     
248. HARRIS E
     Meta-analysis: COVID-19 Infection Protects Against Severe Disease.
     JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2885.
     PubMed    
     
     
     
249. HARRIS E
     Prior COVID-19 Infection Tied to Lasting Lung Abnormalities.
     JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2886.
     PubMed    
     
     
     February 2023
250. NEPRASH HT, Golberstein E, Ganguli I, Chernew ME, et al
     Association of Evaluation and Management Payment Policy Changes With Medicare Payment to Physicians by Specialty.
     JAMA. 2023;329:662-669.
     PubMed     Abstract available
     
     
     
251. HARRIS E
     Study: No New SARS-CoV-2 Variants in Recent Outbreak in China.
     JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2089.
     PubMed    
     
     
     
252. HARRIS E
     COVID-19 Vaccination During Pregnancy Protected Infants.
     JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2098.
     PubMed    
     
     
     
253. LARKIN H
     National Academies: Expand US Wastewater Disease Surveillance.
     JAMA. 2023;329:531.
     PubMed    
     
     
     
254. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
     Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
     JAMA. 2023 Feb 20:e231650. doi: 10.1001/jama.2023.1650.
     PubMed     Abstract available
     
     
     
255. BIBBINS-DOMINGO K, Malani PN
     At a Higher Dose and Longer Duration, Ivermectin Still Not Effective Against COVID-19.
     JAMA. 2023 Feb 20. doi: 10.1001/jama.2023.1922.
     PubMed    
     
     
     
256. HARRIS E
     NIH Considers Lessons Learned During COVID-19 Pandemic.
     JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1553.
     PubMed    
     
     
     
257. HARRIS E
     Most COVID-19 Deaths Worldwide Were Among Older People.
     JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1554.
     PubMed    
     
     
     
258. RUBIN R
     Questions Remain About What SARS-CoV-2 Variants Should Go Into the Annual COVID-19 Vaccines Proposed by the FDA.
     JAMA. 2023 Feb 15. doi: 10.1001/jama.2022.22285.
     PubMed    
     
     
     
259. CHANG R
     SARS-CoV-2 Infection and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents.
     JAMA. 2023;329:512.
     PubMed    
     
     
     
260. REWERS M, Ziegler AG
     SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents-Reply.
     JAMA. 2023;329:512-513.
     PubMed    
     
     
     
261. HARRIS E
     Updated COVID-19 Guidance for People Who Are Immunocompromised.
     JAMA. 2023 Feb 8. doi: 10.1001/jama.2023.1176.
     PubMed    
     
     
     
262. HONG KH, Sung H
     SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents.
     JAMA. 2023;329:424-425.
     PubMed    
     
     
     
263. CHU WM, Wang CY, Wei JC
     Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection.
     JAMA. 2023;329:426.
     PubMed    
     
     
     
264. WAGGONER JJ, Tyburski EA, Lam WA
     SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents-Reply.
     JAMA. 2023;329:425-426.
     PubMed    
     
     
     
265. HUH K, Kim YE, Jung J
     Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection-Reply.
     JAMA. 2023;329:426-427.
     PubMed    
     
     
     
266. LARKIN H
     Newly Discovered Host-Cell Factor Could Be a COVID-19 Treatment Target.
     JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0748.
     PubMed    
     
     
     
267. LARKIN H
     High COVID-19 Rates Prompt Call for Better Nursing Home Protections.
     JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0740.
     PubMed    
     
     
     
268. LARKIN H
     Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
     JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0743.
     PubMed    
     
     
     January 2023
269. ROLFES MA, Talbot HK, McLean HQ, Stockwell MS, et al
     Household Transmission of Influenza A Viruses in 2021-2022.
     JAMA. 2023 Jan 26. doi: 10.1001/jama.2023.0064.
     PubMed     Abstract available
     
     
     
270. HARRIS E
     NIH Funds Research on Severe COVID-19-Related Illness in Children.
     JAMA. 2023 Jan 25. doi: 10.1001/jama.2023.0391.
     PubMed    
     
     
     
271. RUBIN R
     Large Cohort Study Finds Possible Association Between Postural Orthostatic Tachycardia Syndrome and COVID-19 Vaccination but Far Stronger Link With SARS-CoV-2 Infection.
     JAMA. 2023 Jan 25. doi: 10.1001/jama.2023.0050.
     PubMed    
     
     
     
272. LARKIN HD
     Patients With Mild COVID-19 at Risk of Some Post-COVID-19 Condition Symptoms.
     JAMA. 2023 Jan 18. doi: 10.1001/jama.2022.24498.
     PubMed    
     
     
     
273. LARKIN HD
     NIH Pilots Telehealth Program for COVID-19.
     JAMA. 2023 Jan 18. doi: 10.1001/jama.2022.24494.
     PubMed    
     
     
     
274. BHIMRAJ A, Gallagher JC
     Lack of Benefit of Fluvoxamine for COVID-19.
     JAMA. 2023 Jan 12. doi: 10.1001/jama.2022.23954.
     PubMed    
     
     
     
275. MCCARTHY MW, Naggie S, Boulware DR, Lindsell CJ, et al
     Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
     JAMA. 2023 Jan 12. doi: 10.1001/jama.2022.24100.
     PubMed     Abstract available
     
     
     
276. RUBIN R
     Swab the Throat as Well as the Nose? The Debate Over the Best Way to Test for SARS-CoV-2.
     JAMA. 2023 Jan 11. doi: 10.1001/jama.2022.23311.
     PubMed    
     
     
     
277. HOLMGREN AJ, Byron ME, Grouse CK, Adler-Milstein J, et al
     Association Between Billing Patient Portal Messages as e-Visits and Patient Messaging Volume.
     JAMA. 2023 Jan 6. doi: 10.1001/jama.2022.24710.
     PubMed    
     
     
     
278. LARKIN H
     Combined COVID-19 and Flu Test Authorized for Point-of-Care Use.
     JAMA. 2023;329:14-15.
     PubMed    
     
     
     December 2022
279. SURAN M
     VA Finds Nirmatrelvir Associated With Lower Risk of Long COVID.
     JAMA. 2022;328:2386.
     PubMed    
     
     
     
280. SURAN M
     HHS Releases New Report on Long COVID Experiences.
     JAMA. 2022;328:2386.
     PubMed    
     
     
     
281. YII CY, Yong SB, Wei JC
     COVID-19 vs Influenza for Risk of Thrombotic Events in Hospitalized Patients.
     JAMA. 2022;328:2457-2458.
     PubMed    
     
     
     
282. LO RE V 3RD, Dutcher SK, Cocoros NM
     COVID-19 vs Influenza for Risk of Thrombotic Events in Hospitalized Patients-Reply.
     JAMA. 2022;328:2458-2459.
     PubMed    
     
     
     
283. SLOMSKI A
     Angiotensin Receptor Blockers Not Effective Against COVID-19.
     JAMA. 2022;328:2387.
     PubMed    
     
     
     
284. SLOMSKI A
     Moderna COVID-19 Vaccine Safe and Effective for Children 6 Months to 5 Years.
     JAMA. 2022;328:2388.
     PubMed    
     
     
     
285. MANGURIAN C
     Getting Treated for COVID-19 Shouldn't Be This Difficult.
     JAMA. 2022 Dec 22. doi: 10.1001/jama.2022.23155.
     PubMed    
     
     
     
286. LARKIN H
     Dogs May Reliably Detect SARS-CoV-2 Infections at Mass Events.
     JAMA. 2022;328:2294.
     PubMed    
     
     
     
287. LARKIN H
     How Early COVID-19 Restrictions Effected Progress on Neglected Tropical Diseases.
     JAMA. 2022;328:2294-2295.
     PubMed    
     
     
     
288. BARNETT ML, Sax PE
     Long-term Follow-up After Critical COVID-19: REMAP-CAP Revisited.
     JAMA. 2022 Dec 16. doi: 10.1001/jama.2022.23700.
     PubMed    
     
     
     
289. HIGGINS AM, Berry LR, Lorenzi E, Murthy S, et al
     Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
     JAMA. 2022 Dec 16. doi: 10.1001/jama.2022.23257.
     PubMed     Abstract available
     
     
     
290. ABBASI J
     Amid Ohio Measles Outbreak, New Global Report Warns of Decreased Vaccination During COVID-19 Pandemic.
     JAMA. 2022 Dec 15. doi: 10.1001/jama.2022.23241.
     PubMed    
     
     
     
291. MARKS PW, Gruppuso PA, Adashi EY
     Urgent Need for Next-Generation COVID-19 Vaccines.
     JAMA. 2022 Dec 9. doi: 10.1001/jama.2022.22759.
     PubMed    
     
     
     
292. LARKIN HD
     Novavax COVID-19 Vaccine Booster Authorized.
     JAMA. 2022;328:2101.
     PubMed    
     
     
     
293. BRUZELIUS E, Martins SS
     US Trends in Drug Overdose Mortality Among Pregnant and Postpartum Persons, 2017-2020.
     JAMA. 2022;328:2159-2161.
     PubMed    
     
     
     
294. BUENO DE MESQUITA PJ, Sokas R
     SARS-CoV-2 Reduction in Shared Indoor Air.
     JAMA. 2022;328:2163.
     PubMed    
     
     
     
295. SRIKRISHNA D, Karan A, Dhillon RS
     SARS-CoV-2 Reduction in Shared Indoor Air.
     JAMA. 2022;328:2162-2163.
     PubMed    
     
     
     
296. MANMADHAN A, Ahuja T
     Association Between COVID-19 Booster Vaccination and Omicron Infection in a Cohort of Players and Staff in the National Basketball Association.
     JAMA. 2022;328:2164-2165.
     PubMed    
     
     
     
297. DOWELL D, Lindsley WG, Brooks JT
     SARS-CoV-2 Reduction in Shared Indoor Air-Reply.
     JAMA. 2022;328:2163-2164.
     PubMed    
     
     
     
298. MACK CD, Anderson DJ, DiFiori J
     Association Between COVID-19 Booster Vaccination and Omicron Infection in a Cohort of Players and Staff in the National Basketball Association-Reply.
     JAMA. 2022;328:2165.
     PubMed    
     
     
     
299. GANDHI RT, Bedimo R, Hoy JF, Landovitz RJ, et al
     Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.
     JAMA. 2022 Dec 1. doi: 10.1001/jama.2022.22246.
     PubMed     Abstract available
     
     
     November 2022
300. ABBASI J
     Highlights From the American Heart Association's Scientific Sessions 2022-COVID-19's Ripple Effects, a Triglyceride Disappointment, Gene Editing Advances, and More.
     JAMA. 2022 Nov 23. doi: 10.1001/jama.2022.17757.
     PubMed    
     
     
     
301. SLOMSKI A
     Intranasal COVID-19 Vaccine Disappointing in First-in-Human Trial.
     JAMA. 2022;328:2003.
     PubMed    
     
     
     
302. BILINSKI A, Thompson K, Emanuel E
     COVID-19 and Excess All-Cause Mortality in the US and 20 Comparison Countries, June 2021-March 2022.
     JAMA. 2022 Nov 18. pii: 2798990. doi: 10.1001/jama.2022.21795.
     PubMed    
     
     
     
303. RUBIN R
     How Immune-Evasive Omicron Offspring and a Lack of Mitigation Measures Could Shape a COVID-19 Winter Wave.
     JAMA. 2022 Nov 16. pii: 2798913. doi: 10.1001/jama.2022.17758.
     PubMed    
     
     
     
304. YEK C, Kadri SS
     Massachusetts Data on Excess Mortality During the Delta and Omicron Waves of COVID-19.
     JAMA. 2022;328:1977.
     PubMed    
     
     
     
305. FAUST JS, Renton B, Du C
     Massachusetts Data on Excess Mortality During the Delta and Omicron Waves of COVID-19.
     JAMA. 2022;328:1977-1978.
     PubMed    
     
     
     
306. LARKIN HD
     COVID-19 Limited Access to Sexual and Reproductive Health Services.
     JAMA. 2022;328:1896-1897.
     PubMed    
     
     
     
307. SURAN M
     Highlights From Infectious Disease Week 2022-COVID-19, HIV, Monkeypox, and Polio.
     JAMA. 2022 Nov 9. pii: 2798547. doi: 10.1001/jama.2022.17754.
     PubMed    
     
     
     
308. KUEHN BM
     Second COVID-19 Booster Increases Protection for Nursing Home Patients.
     JAMA. 2022;328:1800-1801.
     PubMed    
     
     
     October 2022
309. BERNARD SA, Bray JE, Smith K, Stephenson M, et al
     Effect of Lower vs Higher Oxygen Saturation Targets on Survival to Hospital Discharge Among Patients Resuscitated After Out-of-Hospital Cardiac Arrest: The EXACT Randomized Clinical Trial.
     JAMA. 2022 Oct 26. pii: 2798013. doi: 10.1001/jama.2022.17701.
     PubMed     Abstract available
     
     
     
310. SURAN M
     VA Guidebook on Long COVID.
     JAMA. 2022;328:1580.
     PubMed    
     
     
     
311. SLOMSKI A
     Vitamin D Supplements Don't Reduce COVID-19 Risk.
     JAMA. 2022;328:1581.
     PubMed    
     
     
     
312. WALKER MD, Shane E
     Hypercalcemia: A Review.
     JAMA. 2022;328:1624-1636.
     PubMed     Abstract available
     
     
     
313. FRIEDEN TR, McClelland A
     Preparing for Pandemics and Other Health Threats: Societal Approaches to Protect and Improve Health.
     JAMA. 2022;328:1585-1586.
     PubMed    
     
     
     
314. EISENBERG MD, Eddelbuettel JCP, McGinty EE
     Employment in Office-Based and Intensive Behavioral Health Settings in the US, 2016-2021.
     JAMA. 2022;328:1642-1643.
     PubMed    
     
     
     
315. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
     Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
     JAMA. 2022 Oct 21. pii: 2797483. doi: 10.1001/jama.2022.18590.
     PubMed     Abstract available
     
     
     
316. JIANG Q, Zhang YF, Hu P
     Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel.
     JAMA. 2022;328:1561-1562.
     PubMed    
     
     
     
317. SHAVIT I, Koppel JH, Levy N
     Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel-Reply.
     JAMA. 2022;328:1562.
     PubMed    
     
     
     
318. THOMPSON MG, Yoon SK, Naleway AL, Meece J, et al
     Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
     JAMA. 2022;328:1523-1533.
     PubMed     Abstract available
     
     
     
319. BELLANDI D
     Estimate: 10.5 Million Children Lost a Parent, Caregiver to COVID-19.
     JAMA. 2022;328:1490.
     PubMed    
     
     
     
320. HSU CK, Lai CC
     Risk of Infection and Hospitalization Among Children and Adolescents in New York After Emergence of the SARS-CoV-2 Omicron Variant.
     JAMA. 2022;328:1460.
     PubMed    
     
     
     
321. DORABAWILA V, Bassett MT, Rosenberg ES
     Risk of Infection and Hospitalization Among Children and Adolescents in New York After Emergence of the SARS-CoV-2 Omicron Variant-Reply.
     JAMA. 2022;328:1460-1461.
     PubMed    
     
     
     
322. KUEHN BM
     Lowest US Life Expectancy Since 1996 Linked to COVID-19.
     JAMA. 2022;328:1389.
     PubMed    
     
     
     
323. WULF HANSON S, Abbafati C, Aerts JG, Al-Aly Z, et al
     Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
     JAMA. 2022 Oct 10. pii: 2797443. doi: 10.1001/jama.2022.18931.
     PubMed     Abstract available
     
     
     
324. ABBASI J
     White House Advisor Nahid Bhadelia, MD, MALD, on COVID-19 in Resource-Limited Nations-Undercounted Deaths, Vaccine Inequity, and More.
     JAMA. 2022 Oct 5. pii: 2797281. doi: 10.1001/jama.2022.13663.
     PubMed    
     
     
     
325. SLOMSKI A
     Long COVID in Children.
     JAMA. 2022;328:1288.
     PubMed    
     
     
     
326. GERSHENGORN HB
     Effect of Awake Prone Positioning on Patients With COVID-19 and Acute Respiratory Failure.
     JAMA. 2022;328:1353-1354.
     PubMed    
     
     
     
327. RAGHUNATHAN K, Raghunathan A
     Effect of Awake Prone Positioning on Patients With COVID-19 and Acute Respiratory Failure.
     JAMA. 2022;328:1354.
     PubMed    
     
     
     
328. ALHAZZANI W, Weatherald J, Arabi YM
     Effect of Awake Prone Positioning on Patients With COVID-19 and Acute Respiratory Failure-Reply.
     JAMA. 2022;328:1354-1355.
     PubMed    
     
     
     September 2022
329. GARDNER L
     The COVID-19 Dashboard for Real-time Tracking of the Pandemic: The Lasker-Bloomberg Public Service Award.
     JAMA. 2022 Sep 28. pii: 2796722. doi: 10.1001/jama.2022.15590.
     PubMed    
     
     
     
330. NICHOL AD, O'Kane C, McAuley DF
     Respiratory Support in the Time of COVID-19.
     JAMA. 2022;328:1203-1205.
     PubMed    
     
     
     
331. SLOMSKI A
     Repurposed Drugs Failed to Prevent Severe COVID-19.
     JAMA. 2022;328:1171.
     PubMed    
     
     
     
332. FRAT JP, Quenot JP, Badie J, Coudroy R, et al
     Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19: The SOHO-COVID Randomized Clinical Trial.
     JAMA. 2022;328:1212-1222.
     PubMed     Abstract available
     
     
     
333. KUEHN BM
     Bus and Urban Transit Workers Have Highest COVID-19 Risk.
     JAMA. 2022;328:1173.
     PubMed    
     
     
     
334. KELLY JD, Leonard S, Hoggatt KJ, Boscardin WJ, et al
     Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.
     JAMA. 2022 Sep 26. pii: 2796892. doi: 10.1001/jama.2022.17985.
     PubMed     Abstract available
     
     
     
335. TENFORDE MW, Link-Gelles R, Patel MM
     Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.
     JAMA. 2022 Sep 26. pii: 2796894. doi: 10.1001/jama.2022.14660.
     PubMed    
     
     
     
336. LIN DY, Gu Y, Xu Y, Wheeler B, et al
     Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes.
     JAMA. 2022 Sep 26. pii: 2796893. doi: 10.1001/jama.2022.17876.
     PubMed     Abstract available
     
     
     
337. RIDGWAY JP, Tideman S, French T, Wright B, et al
     Odds of Hospitalization for COVID-19 After 3 vs 2 Doses of mRNA COVID-19 Vaccine by Time Since Booster Dose.
     JAMA. 2022 Sep 23. pii: 2796847. doi: 10.1001/jama.2022.17811.
     PubMed    
     
     
     
338. RUBIN R
     The Dreaded "Twindemic" of Influenza and COVID-19 Has Not Yet Materialized-Might This Be the Year?
     JAMA. 2022 Sep 21. pii: 2796806. doi: 10.1001/jama.2022.15062.
     PubMed    
     
     
     
339. ARABI YM, Aldekhyl S, Al Qahtani S, Al-Dorzi HM, et al
     Effect of Helmet Noninvasive Ventilation vs Usual Respiratory Support on Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19: The HELMET-COVID Randomized Clinical Trial.
     JAMA. 2022;328:1063-1072.
     PubMed     Abstract available
     
     
     
340. LARKIN HD
     COVID-19 Health Policies and Economies in Nordic Countries.
     JAMA. 2022;328:1029.
     PubMed    
     
     
     
341. MATTA S, Nicholas LH
     Changes in Unemployment Among Health Care Workers Following the COVID-19 Pandemic.
     JAMA. 2022 Sep 19. pii: 2796661. doi: 10.1001/jama.2022.17608.
     PubMed    
     
     
     
342. LARKIN HD
     New Data on Heterologous COVID-19 Vaccine Combinations.
     JAMA. 2022;328:916-917.
     PubMed    
     
     
     
343. LARKIN HD
     Antibody Found in Mice Neutralizes SARS-CoV-2 and SARS-CoV-1.
     JAMA. 2022;328:916-917.
     PubMed    
     
     
     
344. KUEHN BM
     CDC Streamlines COVID-19 Guidance.
     JAMA. 2022;328:918-919.
     PubMed    
     
     
     
345. WEBBER C, Myran DT, Milani C, Turcotte L, et al
     Cognitive Decline in Long-term Care Residents Before and During the COVID-19 Pandemic in Ontario, Canada.
     JAMA. 2022 Sep 12. pii: 2796449. doi: 10.1001/jama.2022.17214.
     PubMed    
     
     
     
346. ABBASI J
     The US Now Has a Research Plan for Long COVID-Is It Enough?
     JAMA. 2022;328:812-814.
     PubMed    
     
     
     August 2022
347. BARNETT ML, Waken RJ, Zheng J, Orav EJ, et al
     Changes in Health and Quality of Life in US Skilled Nursing Facilities by COVID-19 Exposure Status in 2020.
     JAMA. 2022 Aug 29. pii: 2795935. doi: 10.1001/jama.2022.15071.
     PubMed     Abstract available
     
     
     
348. YOUNGSTER I
     Self-sampling for SARS-CoV-2 Detection in Children.
     JAMA. 2022 Aug 26. pii: 2795838. doi: 10.1001/jama.2022.15225.
     PubMed    
     
     
     
349. WAGGONER JJ, Vos MB, Tyburski EA, Nguyen PV, et al
     Concordance of SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents.
     JAMA. 2022 Aug 26. pii: 2795837. doi: 10.1001/jama.2022.14877.
     PubMed     Abstract available
     
     
     
350. SOLIS-MOREIRA J
     Study: New Wastewater Surveillance Method Detected SARS-CoV-2 Variants of Concern Up to 2 Weeks Before Clinical Tests.
     JAMA. 2022 Aug 24. pii: 2795815. doi: 10.1001/jama.2022.12563.
     PubMed    
     
     
     
351. RUBIN R
     Despite Its Fan Base, Newly Authorized "Traditional" Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US.
     JAMA. 2022 Aug 24. pii: 2795814. doi: 10.1001/jama.2022.13661.
     PubMed    
     
     
     
352. SURAN M
     Free COVID-19 Tests for People With Visual Impairment.
     JAMA. 2022;328:699.
     PubMed    
     
     
     
353. SLOMSKI A
     Antibody Testing's Limits for Detecting Prior SARS-CoV-2 Infection.
     JAMA. 2022;328:700-701.
     PubMed    
     
     
     
354. RUBIN R
     Pharmacists Allowed to Prescribe COVID-19 Antiviral.
     JAMA. 2022;328:612.
     PubMed    
     
     
     
355. LO RE V 3RD, Dutcher SK, Connolly JG, Perez-Vilar S, et al
     Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
     JAMA. 2022;328:637-651.
     PubMed     Abstract available
     
     
     
356. LARKIN HD
     Preventing COVID-19, Saving Lives in Lower-Income Countries.
     JAMA. 2022;328:611.
     PubMed    
     
     
     
357. KUEHN BM
     Reduced HIV Testing and Diagnoses During COVID-19 Pandemic.
     JAMA. 2022;328:519.
     PubMed    
     
     
     
358. LARKIN HD
     Evolving Omicron Subvariants Are More Resistant to Antibody Therapy.
     JAMA. 2022;328:518.
     PubMed    
     
     
     
359. REWERS M, Bonifacio E, Ewald D, Geno Rasmussen C, et al
     SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany.
     JAMA. 2022 Aug 5. pii: 2795226. doi: 10.1001/jama.2022.14092.
     PubMed    
     
     
     
360. MADHUSOODANAN J
     Animal Reservoirs-Where the Next SARS-CoV-2 Variant Could Arise.
     JAMA. 2022 Aug 3. pii: 2795140. doi: 10.1001/jama.2022.9789.
     PubMed    
     
     
     
361. LEVINE RL
     Addressing the Long-term Effects of COVID-19.
     JAMA. 2022 Aug 3. pii: 2795139. doi: 10.1001/jama.2022.14089.
     PubMed    
     
     
     
362. SLOMSKI A
     Sickle Cell Trait Associated With Kidney Failure and COVID-19 Death.
     JAMA. 2022;328:415.
     PubMed    
     
     
     
363. SLOMSKI A
     Maternal Death Rate Increased During Early COVID-19 Pandemic.
     JAMA. 2022;328:415.
     PubMed    
     
     
     
364. GENZEN JR, Rychert J, George TI
     Integrity of SARS-CoV-2 Laboratory-Developed Tests.
     JAMA. 2022;328:478.
     PubMed    
     
     
     
365. ADASHI EY, Cohen G
     Integrity of SARS-CoV-2 Laboratory-Developed Tests-Reply.
     JAMA. 2022;328:478-479.
     PubMed    
     
     
     
366. BIRNIE E, Biemond JJ, Appelman B, de Bree GJ, et al
     Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant.
     JAMA. 2022 Aug 1. pii: 2794999. doi: 10.1001/jama.2022.13854.
     PubMed    
     
     
     July 2022
367. VASAN A, Foote M, Long T
     Ensuring Widespread and Equitable Access to Treatments for COVID-19.
     JAMA. 2022 Jul 29. pii: 2794967. doi: 10.1001/jama.2022.13554.
     PubMed    
     
     
     
368. ZENG G
     SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.
     JAMA. 2022;328:395.
     PubMed    
     
     
     
369. ULLOA AC, Buchan SA, Brown KA
     SARS-CoV-2 Omicron Variant Severity in Ontario, Canada-Reply.
     JAMA. 2022;328:395-396.
     PubMed    
     
     
     
370. SLOMSKI A
     Evusheld Reduces COVID-19 Disease Severity Among Unvaccinated Adults.
     JAMA. 2022;328:322.
     PubMed    
     
     
     
371. KUEHN BM
     Persistent Disparities in COVID-19 Antiviral Dispensing.
     JAMA. 2022;328:323.
     PubMed    
     
     
     
372. MALANI AG, Malani AN
     Preventive Medication for COVID-19 Infection.
     JAMA. 2022 Jul 25. pii: 2794799. doi: 10.1001/jama.2022.13214.
     PubMed    
     
     
     
373. KIM YE, Huh K, Park YJ, Peck KR, et al
     Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.
     JAMA. 2022 Jul 22. pii: 2794753. doi: 10.1001/jama.2022.12992.
     PubMed    
     
     
     
374. WEBER E, Van Buren N, Cunningham T
     COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge.
     JAMA. 2022;328:301-302.
     PubMed    
     
     
     
375. LIN HY, Chen MH, Liang CS
     COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge.
     JAMA. 2022;328:301.
     PubMed    
     
     
     
376. KENIK J
     Remote Patient Monitoring During COVID-19.
     JAMA. 2022;328:302-303.
     PubMed    
     
     
     
377. AZOULAY E, Pochard F, Kentish-Barnes N
     COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge-Reply.
     JAMA. 2022;328:302.
     PubMed    
     
     
     
378. PRONOVOST PJ, Cole MD, Hughes RM
     Remote Patient Monitoring During COVID-19-Reply.
     JAMA. 2022;328:303-304.
     PubMed    
     
     
     
379. LARKIN HD
     Mix-and-Match COVID-19 Boosters After Inactivated Virus Vaccine.
     JAMA. 2022;328:234.
     PubMed    
     
     
     
380. RUBIN R
     COVID-19 Boosters This Fall to Include Omicron Antigen, but Questions Remain About Its Value.
     JAMA. 2022 Jul 8. pii: 2794259. doi: 10.1001/jama.2022.11252.
     PubMed    
     
     
     
381. SCHWANDT H, Currie J, von Wachter T, Kowarski J, et al
     Changes in the Relationship Between Income and Life Expectancy Before and During the COVID-19 Pandemic, California, 2015-2021.
     JAMA. 2022 Jul 7. pii: 2794146. doi: 10.1001/jama.2022.10952.
     PubMed     Abstract available
     
     
     
382. LARKIN HD
     First Nonprescription COVID-19 Test That Also Detects Flu and RSV.
     JAMA. 2022;328:11.
     PubMed    
     
     
     
383. LARKIN HD
     Expiration Dates Extended on COVID-19 Monoclonal Antibody Therapies.
     JAMA. 2022;328:11.
     PubMed    
     
     
     
384. KUEHN BM
     WHO: Pandemic Sparked a Push for Global Mental Health Transformation.
     JAMA. 2022;328:5-7.
     PubMed    
     
     
     
385. AZZOLINI E, Levi R, Sarti R, Pozzi C, et al
     Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers.
     JAMA. 2022 Jul 1. pii: 2794072. doi: 10.1001/jama.2022.11691.
     PubMed    
     
     
     June 2022
386. RUDYM D, Chang SH, Angel LF
     Characteristics and Outcomes of Patients With COVID-19-Associated ARDS Who Underwent Lung Transplant.
     JAMA. 2022;327:2454.
     PubMed    
     
     
     
387. MANERIKAR A, Budinger GRS, Bharat A
     Characteristics and Outcomes of Patients With COVID-19-Associated ARDS Who Underwent Lung Transplant-Reply.
     JAMA. 2022;327:2454-2455.
     PubMed    
     
     
     
388. CARDOSO CC, Rossi AD, Galliez RM, Faffe DS, et al
     Olfactory Dysfunction in Patients With Mild COVID-19 During Gamma, Delta, and Omicron Waves in Rio de Janeiro, Brazil.
     JAMA. 2022 Jun 24. pii: 2793811. doi: 10.1001/jama.2022.11006.
     PubMed    
     
     
     
389. ABBASI J
     COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies.
     JAMA. 2022 Jun 22. pii: 2793740. doi: 10.1001/jama.2022.11145.
     PubMed    
     
     
     
390. RUBIN R
     Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment.
     JAMA. 2022;327:2281.
     PubMed    
     
     
     
391. LARKIN HD
     mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
     JAMA. 2022;327:2280.
     PubMed    
     
     
     
392. KLOMPAS M, Pandolfi MC, Nisar AB, Baker MA, et al
     Association of Omicron vs Wild-type SARS-CoV-2 Variants With Hospital-Onset SARS-CoV-2 Infections in a US Regional Hospital System.
     JAMA. 2022 Jun 15. pii: 2793582. doi: 10.1001/jama.2022.9609.
     PubMed    
     
     
     
393. HAMAD R, Galea S
     The Role of Health Care Systems in Bolstering the Social Safety Net to Address Health Inequities in the Wake of the COVID-19 Pandemic.
     JAMA. 2022 Jun 15. pii: 2793581. doi: 10.1001/jama.2022.10160.
     PubMed    
     
     
     
394. LARKIN HD
     Urine Test Detects SARS-CoV-2 Antibodies.
     JAMA. 2022;327:2182.
     PubMed    
     
     
     
395. FARMAKIOTIS D
     COVID-19 Treatments for Nonhospitalized Patients.
     JAMA. 2022;327:2247.
     PubMed    
     
     
     
396. CAYLEY WE JR
     COVID-19 Treatments for Nonhospitalized Patients.
     JAMA. 2022;327:2248.
     PubMed    
     
     
     
397. GANDHI RT, Malani PN, Del Rio C
     COVID-19 Treatments for Nonhospitalized Patients-Reply.
     JAMA. 2022;327:2248.
     PubMed    
     
     
     
398. KATZ SE, Edwards K
     Protecting Children Against Omicron.
     JAMA. 2022;327:2195-2197.
     PubMed    
     
     
     
399. JONES JM, Opsomer JD, Stone M, Benoit T, et al
     Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.
     JAMA. 2022 Jun 13. pii: 2793517. doi: 10.1001/jama.2022.9745.
     PubMed    
     
     
     
400. RUBIN R
     From Positive to Negative to Positive Again-The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid.
     JAMA. 2022 Jun 8. pii: 2793357. doi: 10.1001/jama.2022.9925.
     PubMed    
     
     
     
401. DOWELL D, Lindsley WG, Brooks JT
     Reducing SARS-CoV-2 in Shared Indoor Air.
     JAMA. 2022 Jun 7. pii: 2793289. doi: 10.1001/jama.2022.9970.
     PubMed    
     
     
     
402. LARKIN HD
     Warning Against Counterfeit At-home COVID-19 Tests.
     JAMA. 2022;327:2067.
     PubMed    
     
     
     
403. LI Y
     Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave.
     JAMA. 2022;327:2147-2148.
     PubMed    
     
     
     
404. LATRONICO N, Rasulo FA, Piva S
     Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
     JAMA. 2022;327:2149.
     PubMed    
     
     
     
405. BAI W, Jackson T, Xiang YT
     Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
     JAMA. 2022;327:2148-2149.
     PubMed    
     
     
     
406. SEVIN CM, Ely EW
     Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
     JAMA. 2022;327:2149-2150.
     PubMed    
     
     
     
407. MASLO C, Toubkin M
     Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave-Reply.
     JAMA. 2022;327:2148.
     PubMed    
     
     
     
408. HEESAKKERS H, van den Boogaard M, Zegers M
     Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19-Reply.
     JAMA. 2022;327:2150-2151.
     PubMed    
     
     
     
409. VIJAY A, Yancy CW
     Resident Physician Wellness Postpandemic: How Does Healing Occur?
     JAMA. 2022;327:2077-2078.
     PubMed    
     
     
     
410. TAI CG, Maragakis LL, Connolly S, DiFiori J, et al
     Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.
     JAMA. 2022 Jun 2. pii: 2793169. doi: 10.1001/jama.2022.9479.
     PubMed    
     
     
     
411. RUBIN R
     Challenges of Deciding Whether and How to Update COVID-19 Vaccines to Protect Against Variants.
     JAMA. 2022 Jun 1. pii: 2793149. doi: 10.1001/jama.2022.9367.
     PubMed    
     
     
     May 2022
412. DEL RIO C, Malani PN
     COVID-19 in 2022-The Beginning of the End or the End of the Beginning?
     JAMA. 2022 May 27. pii: 2793011. doi: 10.1001/jama.2022.9655.
     PubMed    
     
     
     
413. WEISS SR
     Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
     JAMA. 2022;327:2019-2020.
     PubMed    
     
     
     
414. PEREZ-FERNANDEZ XL, Fuset-Cabanes M, Hernandez-Platero L
     Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19.
     JAMA. 2022;327:2022-2023.
     PubMed    
     
     
     
415. YARNELL CJ, Sklar MC
     Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19.
     JAMA. 2022;327:2023.
     PubMed    
     
     
     
416. OSTER ME, Shay DK, Shimabukuro TT
     Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
     JAMA. 2022;327:2020-2021.
     PubMed    
     
     
     
417. COUPER K, Connolly BA, McAuley DF
     Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19-Reply.
     JAMA. 2022;327:2023-2024.
     PubMed    
     
     
     
418. KUEHN BM
     Cardiac Complications More Common After COVID-19 Than Vaccination.
     JAMA. 2022;327:1951.
     PubMed    
     
     
     
419. FAUST JS, Du C, Liang C, Mayes KD, et al
     Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19.
     JAMA. 2022 May 20. pii: 2792738. doi: 10.1001/jama.2022.8045.
     PubMed    
     
     
     
420. LEVY N, Koppel JH, Kaplan O, Yechiam H, et al
     Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel.
     JAMA. 2022 May 19. pii: 2792718. doi: 10.1001/jama.2022.8025.
     PubMed    
     
     
     
421. RUBIN R
     SARS-CoV-2 RNA Can Persist in Stool Months After Respiratory Tract Clears Virus.
     JAMA. 2022 May 18. pii: 2792688. doi: 10.1001/jama.2022.7892.
     PubMed    
     
     
     
422. BELLANDI D, Voelker R
     New White House COVID-19 Leader on What's Next.
     JAMA. 2022 May 18. pii: 2792686. doi: 10.1001/jama.2022.8541.
     PubMed    
     
     
     
423. RUBIN R
     First Breathalyzer Test to Diagnose COVID-19.
     JAMA. 2022;327:1860.
     PubMed    
     
     
     
424. BEZERRA MF
     Rapid Antigen Tests for SARS-CoV-2.
     JAMA. 2022;327:1925-1926.
     PubMed    
     
     
     
425. GANS JS, Goldfarb A, Rosella L
     Rapid Antigen Tests for SARS-CoV-2-Reply.
     JAMA. 2022;327:1926.
     PubMed    
     
     
     
426. SHIROKY-KOCHAVI J
     The Pandemic Determinants of Health.
     JAMA. 2022;327:1869.
     PubMed    
     
     
     
427. ALHAZZANI W, Parhar KKS, Weatherald J, Al Duhailib Z, et al
     Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial.
     JAMA. 2022 May 15. pii: 2792506. doi: 10.1001/jama.2022.7993.
     PubMed     Abstract available
     
     
     
428. FLEMING-DUTRA KE, Britton A, Shang N, Derado G, et al
     Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
     JAMA. 2022 May 13. pii: 2792524. doi: 10.1001/jama.2022.7493.
     PubMed     Abstract available
     
     
     
429. DORABAWILA V, Hoefer D, Bauer UE, Bassett MT, et al
     Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.
     JAMA. 2022 May 13. pii: 2792525. doi: 10.1001/jama.2022.7319.
     PubMed    
     
     
     
430. HOURY DE, Simon TR, Crosby AE
     Firearm Homicide and Suicide During the COVID-19 Pandemic: Implications for Clinicians and Health Care Systems.
     JAMA. 2022 May 10. pii: 2792080. doi: 10.1001/jama.2022.6924.
     PubMed    
     
     
     
431. LARKIN HD
     Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3.
     JAMA. 2022;327:1748.
     PubMed    
     
     
     
432. LARKIN HD
     Two mRNA COVID-19 Vaccines Stimulate Different Immune Responses.
     JAMA. 2022;327:1748.
     PubMed    
     
     
     
433. MANGURIAN C, Fitelson EM, Epel E
     COVID-19 and Lessons to Improve Preparedness for the Next Pandemic.
     JAMA. 2022;327:1822-1823.
     PubMed    
     
     
     
434. CHEN J, Al-Azzawi ZAM, Taifour T
     Testing, Surveillance, and Mitigation Strategies for COVID-19.
     JAMA. 2022;327:1824-1825.
     PubMed    
     
     
     
435. NUZZO JB, Gostin LO
     COVID-19 and Lessons to Improve Preparedness for the Next Pandemic-Reply.
     JAMA. 2022;327:1823.
     PubMed    
     
     
     
436. EMANUEL EJ, Michaels D, Bright RA
     Testing, Surveillance, and Mitigation Strategies for COVID-19-Reply.
     JAMA. 2022;327:1825.
     PubMed    
     
     
     
437. KUEHN BM
     mRNA Booster Improves a COVID-19 Vaccine's Effectiveness.
     JAMA. 2022;327:1749.
     PubMed    
     
     
     
438. GANDJOUR A
     Strategy for the "New Normal" of Life With COVID.
     JAMA. 2022;327:1823-1824.
     PubMed    
     
     
     
439. EMANUEL EJ, Osterholm M, Gounder CR
     Strategy for the "New Normal" of Life With COVID-Reply.
     JAMA. 2022;327:1824.
     PubMed    
     
     
     
440. SLOMSKI A
     Studies Examine Risk of Hearing Loss After COVID-19 Vaccination.
     JAMA. 2022;327:1641.
     PubMed    
     
     
     
441. MARKS P, Woodcock J, Califf R
     COVID-19 Vaccination-Becoming Part of the New Normal.
     JAMA. 2022 May 2. pii: 2792030. doi: 10.1001/jama.2022.7469.
     PubMed    
     
     
     
442. MCCLYMONT E, Albert AY, Alton GD, Boucoiran I, et al
     Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes.
     JAMA. 2022 May 2. pii: 2792031. doi: 10.1001/jama.2022.5906.
     PubMed     Abstract available
     
     
     April 2022
443. RUBIN R
     The COVID-19 Pandemic Rages on for People Who Are Immunocompromised.
     JAMA. 2022 Apr 27. pii: 2791868. doi: 10.1001/jama.2022.7281.
     PubMed    
     
     
     
444. SURAN M
     White Individuals Experience Less COVID-19-Related Discrimination.
     JAMA. 2022;327:1538.
     PubMed    
     
     
     
445. KUEHN BM
     COVID-19 Vaccine Effectiveness in Youth Varies by Age, Variant.
     JAMA. 2022;327:1540.
     PubMed    
     
     
     
446. PETTY LA, Malani PN
     Oral Antiviral Medications for COVID-19.
     JAMA. 2022 Apr 25. pii: 2791780. doi: 10.1001/jama.2022.6876.
     PubMed    
     
     
     
447. RAZZAGHI H, Meghani M, Crane B, Ellington S, et al
     Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key Demographics.
     JAMA. 2022 Apr 22. pii: 2791659. doi: 10.1001/jama.2022.6834.
     PubMed    
     
     
     
448. SURAN M
     Stagnant US Mammography Rates and the Influence of COVID-19.
     JAMA. 2022 Apr 20. pii: 2791573. doi: 10.1001/jama.2022.4295.
     PubMed    
     
     
     
449. LARKIN HD
     Global COVID-19 Death Toll May Be Triple the Reported Deaths.
     JAMA. 2022;327:1438.
     PubMed    
     
     
     
450. LARKIN HD
     WHO Urges Monitoring SARS-CoV-2 in Wildlife to Prevent Animal Reservoirs.
     JAMA. 2022;327:1438.
     PubMed    
     
     
     
451. LARKIN HD
     Fractionating COVID-19 Vaccine Doses May Save Lives.
     JAMA. 2022;327:1438.
     PubMed    
     
     
     
452. WOLFSON AR, Freeman EE, Blumenthal KG
     Urticaria 12 Days After COVID-19 mRNA Booster Vaccination.
     JAMA. 2022 Apr 14. pii: 2791317. doi: 10.1001/jama.2022.5247.
     PubMed    
     
     
     
453. ABBASI J
     Large US Study Examines First 6 Months of COVID-19 Vaccine Safety Data.
     JAMA. 2022;327:1323.
     PubMed    
     
     
     
454. KUEHN BM
     Myocarditis Adverse Event Less Common After COVID-19 Vaccine Booster.
     JAMA. 2022;327:1324.
     PubMed    
     
     
     
455. ABBASI J
     Vaccine Booster Dose Appears to Reduce Omicron Hospitalizations.
     JAMA. 2022;327:1323.
     PubMed    
     
     
     
456. TSAY SV, Bartoces M, Gouin K, Kabbani S, et al
     Antibiotic Prescriptions Associated With COVID-19 Outpatient Visits Among Medicare Beneficiaries, April 2020 to April 2021.
     JAMA. 2022 Apr 8. pii: 2791077. doi: 10.1001/jama.2022.5471.
     PubMed    
     
     
     
457. BRADLEY MC, Perez-Vilar S, Chillarige Y, Dong D, et al
     Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021.
     JAMA. 2022 Apr 8. pii: 2791078. doi: 10.1001/jama.2022.4877.
     PubMed    
     
     
     
458. SLOMSKI A
     At-home COVID-19 Test Instructions Frequently Misinterpreted.
     JAMA. 2022;327:1218.
     PubMed    
     
     
     
459. SLOMSKI A
     Maternal COVID-19 Vaccine Safe for Infants.
     JAMA. 2022;327:1218.
     PubMed    
     
     
     
460. NISSEN SE, Wolski K, Balog C, Swerdlow DI, et al
     Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
     JAMA. 2022 Apr 3. pii: 2790912. doi: 10.1001/jama.2022.5050.
     PubMed     Abstract available
     
     
     
461. NATTINO G, Castiglioni S, Cereda D, Della Valle PG, et al
     Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021.
     JAMA. 2022 Apr 1. pii: 2790911. doi: 10.1001/jama.2022.4908.
     PubMed    
     
     
     March 2022
462. SAGE WM, Yang YT
     Reducing "COVID-19 Misinformation" While Preserving Free Speech.
     JAMA. 2022 Mar 31. pii: 2790859. doi: 10.1001/jama.2022.4231.
     PubMed    
     
     
     
463. KHARBANDA EO, Vazquez-Benitez G
     COVID-19 mRNA Vaccines During Pregnancy: New Evidence to Help Address Vaccine Hesitancy.
     JAMA. 2022 Mar 24. pii: 2790610. doi: 10.1001/jama.2022.2459.
     PubMed    
     
     
     
464. ADHIKARI EH, MacDonald L, SoRelle JA, Morse J, et al
     COVID-19 Cases and Disease Severity in Pregnancy and Neonatal Positivity Associated With Delta (B.1.617.2) and Omicron (B.1.1.529) Variant Predominance.
     JAMA. 2022 Mar 24. pii: 2790609. doi: 10.1001/jama.2022.4356.
     PubMed    
     
     
     
465. MAGNUS MC, Ortqvist AK, Dahlqwist E, Ljung R, et al
     Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes.
     JAMA. 2022 Mar 24. pii: 2790608. doi: 10.1001/jama.2022.3271.
     PubMed     Abstract available
     
     
     
466. FELL DB, Dhinsa T, Alton GD, Torok E, et al
     Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes.
     JAMA. 2022 Mar 24. pii: 2790607. doi: 10.1001/jama.2022.4255.
     PubMed     Abstract available
     
     
     
467. ABBASI J
     Even Mild COVID-19 May Change the Brain.
     JAMA. 2022 Mar 23. pii: 2790595. doi: 10.1001/jama.2022.4507.
     PubMed    
     
     
     
468. SURAN M
     COVID-19 Booster Shot Data Now Available From Nursing Homes.
     JAMA. 2022;327:1117.
     PubMed    
     
     
     
469. BRADBURY CA, Lawler PR, Stanworth SJ, McVerry BJ, et al
     Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
     JAMA. 2022 Mar 22. pii: 2790488. doi: 10.1001/jama.2022.2910.
     PubMed     Abstract available
     
     
     
470. CONNORS JM, Ridker PM
     Thromboinflammation and Antithrombotics in COVID-19: Accumulating Evidence and Current Status.
     JAMA. 2022 Mar 22. pii: 2790489. doi: 10.1001/jama.2022.2361.
     PubMed    
     
     
     
471. STEAD W
     One Person.
     JAMA. 2022;327:1131-1132.
     PubMed    
     
     
     
472. WHITE AM, Castle IP, Powell PA, Hingson RW, et al
     Alcohol-Related Deaths During the COVID-19 Pandemic.
     JAMA. 2022 Mar 18. pii: 2790491. doi: 10.1001/jama.2022.4308.
     PubMed    
     
     
     
473. LIEBOWITZ JE, Konig MF
     Joint Pain in a Woman Wearing a Face Mask.
     JAMA. 2022 Mar 17. pii: 2790422. doi: 10.1001/jama.2022.2644.
     PubMed    
     
     
     
474. FRIEDENSOHN L, Levin D, Fadlon-Derai M, Gershovitz L, et al
     Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel.
     JAMA. 2022 Mar 17. pii: 2790421. doi: 10.1001/jama.2022.4425.
     PubMed    
     
     
     
475. LI J, Pavlov I, Ehrmann S
     High-Flow Oxygen vs Conventional Oxygen and Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19.
     JAMA. 2022;327:1092.
     PubMed    
     
     
     
476. OSPINA-TASCON GA, Martinez D, Gempeler A
     High-Flow Oxygen vs Conventional Oxygen and Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19-Reply.
     JAMA. 2022;327:1092-1093.
     PubMed    
     
     
     
477. LARKIN HD
     WHO Releases Report on Maintaining Health Services During COVID-19.
     JAMA. 2022;327:1019.
     PubMed    
     
     
     
478. GUPTA A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, et al
     Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
     JAMA. 2022 Mar 14. pii: 2790246. doi: 10.1001/jama.2022.2832.
     PubMed     Abstract available
     
     
     
479. COREY L, Corbett-Detig R, Beyrer C
     Expanding Efforts and Support to Respond to the HIV and COVID-19 Intersecting Pandemics.
     JAMA. 2022 Mar 11. pii: 2790239. doi: 10.1001/jama.2022.3517.
     PubMed    
     
     
     
480. RUBIN R
     Once Viewed as a Promising COVID-19 Treatment, Convalescent Plasma Falls Out of Favor.
     JAMA. 2022 Mar 9. pii: 2790074. doi: 10.1001/jama.2022.3214.
     PubMed    
     
     
     
481. KUEHN BM
     Racial and Ethnic, Gender Disparities Seen in LGBT COVID-19 Vaccination Rates.
     JAMA. 2022;327:910.
     PubMed    
     
     
     
482. JORGENSEN SB, Nygard K, Kacelnik O, Telle K, et al
     Secondary Attack Rates for Omicron and Delta Variants of SARS-CoV-2 in Norwegian Households.
     JAMA. 2022 Mar 7. pii: 2789920. doi: 10.1001/jama.2022.3780.
     PubMed    
     
     
     
483. ADASHI EY, Cohen IG
     SARS-CoV-2 Laboratory-Developed Tests: Integrity Restored.
     JAMA. 2022 Mar 4. pii: 2789917. doi: 10.1001/jama.2022.3382.
     PubMed    
     
     
     
484. TONELLI M, Warick R
     Focusing on the Needs of People With Hearing Loss During the COVID-19 Pandemic and Beyond.
     JAMA. 2022 Mar 3. pii: 2789772. doi: 10.1001/jama.2022.3026.
     PubMed    
     
     
     
485. ABBASI J
     The COVID Heart-One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks.
     JAMA. 2022 Mar 2. pii: 2789793. doi: 10.1001/jama.2022.2411.
     PubMed    
     
     
     
486. SLOMSKI A
     Metabolic Surgery Associated With Less Severe COVID-19.
     JAMA. 2022;327:804.
     PubMed    
     
     
     
487. GOMES T, Campbell TJ, Kitchen SA, Garg R, et al
     Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
     JAMA. 2022;327:846-855.
     PubMed     Abstract available
     
     
     
488. BROOKS MM, Wisniewski SR
     Assessing Unexpected Circumstances That Lead to Modifications in Clinical Trial Design, Conduct, or Analysis: Application of the CONSERVE Reporting Guideline.
     JAMA. 2022;327:868-869.
     PubMed    
     
     
     October 2021
489. RADWANY S
     Our Best Judgment.
     JAMA. 2021;326:1373-1374.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.